United States · Investor

Beecken Petty O'Keefe & Company

Last cheque observed Dec 2017. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietNew fund $398M, Dec 2019Private equityWebsite unconfirmed

SeedSeries ASeries BHealthier LivingTech-enabled HealthLongevity

Cheques on record
0%of best year0cheques in 12 months, 4 on record
Since the last cheque3234days00hrs00min00sec
Median round$70MRounds led0 of 4Sole investor1 roundsExits2 from the portfolio
Pitch Beecken Petty O'Keefe & Company

Beecken Petty O'Keefe & Company highlights

  1. 01

    4 rounds on record

  2. 02

    Mostly Series B: 100% of its rounds

  3. 03

    Sole investor in 1 rounds, median undisclosed

  4. 04

    2 exits from the portfolio

What they do

Type
Private equity (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries B
Sectors
Healthier LivingTech-enabled HealthLongevity
Based in
Chicago, United States
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first4 appearances

  1. 2017

    1 round

  2. Dec
    AptinyxSeries B · US · FinSMEs$70MWith 15 others
  3. 2006

    1 round

  4. Feb
    Scrip ProductsUSUndisclosedSole investor
  5. 2004

    1 round

  6. Mar
    Jazz PharmaceuticalsSeries B · US$250MWith 8 others
  7. 2002

    1 round

  8. Jan
    CryoCorSeries B · US$12MWith 2 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

Named by the firm itself, on a filing, its Form ADV or its company registration15 named

ALAnn L. KoernerExecutive Officer, PromoteriFiling they signed
DJDavid J. CooneyExecutive Officer, PromoteriFiling they signed
DKDavid K. BeeckenExecutive Officer, PromoteriFiling they signed
GCGladys CordovaChief Financial OfficeriForm ADV
GAGrant A. PatrickExecutive Officer, PromoteriFiling they signed
GAGregory Alan MoerschelManaging Partner; Managing MemberiForm ADV
JWJohn W. KneenExecutive Officer, PromoteriFiling they signed
KWKenneth W. O'KeefeExecutive Officer, PromoteriFiling they signed
MTM. Troy PhillipsExecutive Officer, PromoteriFiling they signed
PNPeter N. MagasExecutive Officer, PromoteriFiling they signed
SRScott R. KabbesExecutive Officer, PromoteriFiling they signed
TAThomas A. SchlesingerExecutive Officer, PromoteriFiling they signed
TDTimothy D. SheehanExecutive Officer, PromoteriFiling they signed
WGWilliam G. PettyExecutive Officer, PromoteriFiling they signed
WGWilliam G. Petty, Jr.Executive Officer, PromoteriFiling they signed

We also hold 32 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

What the register says

From the firm's own filings with the SEC, which it must file accurately by law

$1.9Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
Legal name
BEECKEN PETTY O'KEEFE & COMPANY, LLC
SEC number
CRD 157573

Funds on its Form ADV

9 private funds, $1.6B in gross assets · filed Apr 2024

  1. BPOC Ventus Fund, L.P.Private equity53 investors$595M
  2. Beecken Petty O'Keefe Fund V, L.P.Private equity63 investors$487M
  3. Beecken Petty O'Keefe Fund V-A, L.P.Private equity12 investors$193M
  4. BPOC Fund VI, L.P.Private equity31 investors$160M
  5. Beecken Petty O'Keefe Fund III, L.P.Private equity96 investors$70M
  6. Beecken Petty O'Keefe Fund IV, L.P.Private equity95 investors$60M
  7. BPOC Fund VI-A, L.P.Private equity3 investors$57M
  8. Beecken Petty O'Keefe Fund IV-A, L.P.Private equity9 investors$19M
  9. Beecken Petty O'Keefe Fund III-A, L.P.Private equity5 investors$1.9M

Exits from the portfolio

Companies it backed that were later bought or listed2 in all

CryoCorBought by Boston ScientificUndisclosedMay 2008
Jazz PharmaceuticalsListedUndisclosedMay 2007

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Beecken Petty O'Keefe & Company. A count of rooms they were both in, not a relationship either has claimed.

Recently backed

The latest companies Beecken Petty O'Keefe & Company put money into.

Quick answers about Beecken Petty O'Keefe & Company

What does Beecken Petty O'Keefe & Company invest in?

Beecken Petty O'Keefe & Company invests most often at Series B (100% of the rounds on record), in sectors such as Healthier Living, Tech-enabled Health and Longevity.

How active is Beecken Petty O'Keefe & Company?

4 investments on record, 0 of them in the last 12 months. The most recent was in Dec 2017.

What has Beecken Petty O'Keefe & Company invested in recently?

Its most recent investments on record: Aptinyx (Series B, Dec 2017).

How big are Beecken Petty O'Keefe & Company's cheques?

The median round it joins is $70M.

Is Beecken Petty O'Keefe & Company investing now?

No investments in the last 12 months; the latest was in Dec 2017.

Who does Beecken Petty O'Keefe & Company invest alongside?

Most often Adams Street Partners (2 rounds together).

What kind of investor is Beecken Petty O'Keefe & Company?

Beecken Petty O'Keefe & Company is a private equity firm based in Chicago, United States.

How much does Beecken Petty O'Keefe & Company manage?

About $1.9B, as regulatory assets under management (Oct 2026).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it